Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06124716 · ClinicalTrials.gov registry record · NA

Collaboration Oriented Approach to Controlling High Blood Pressure

A NA study of Hypertension and Multiple Chronic Conditions, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
550
Enrollment target
3
Study locations

NCT06124716: Recruiting NA study of Hypertension and Multiple Chronic Conditions, sponsored by Oregon Health and Science University.

NCT06124716 is a NA study of Hypertension and Multiple Chronic Conditions that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 550 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06124716, a NA study of Hypertension and Multiple Chronic Conditions, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
550 participants
Enrollment target
3
Study locations

Study Summary

Hypertension is a significant contributor to poor cardiovascular outcomes. Self-management support tools can increase patient behaviors to improve blood pressure. The investigators created a clinical decision support app, called COACH, to integrate home blood pressure data and goals into EHR reporting and workflow with communications informed by behavioral economics principles to support shared decision-making. The study aims to measure the effectiveness of the COACH intervention in a pragmatic multi-site randomized trial in a primary care setting.

Primary Outcome

Percent of participants at or below 140/90 (office BP) or 135/85 (home BP) average.

Interventions

  • OTHER Enhanced COACH CDS Tool
  • OTHER Usual Care COACH CDS Tool

Study Locations (3)

Missouri

  • University of Missouri-Columbia - Columbia

Oregon

  • Oregon Health & Science University - Portland

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2024-01-12
Est. Completion 2026-06-30
Phase NA

What NCT06124716 shows while recruiting

NCT06124716 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Enhanced COACH CDS Tool is the first listed.

NCT06124716 reports a single indexed study location in Missouri, Oregon, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06124716 about?

NCT06124716 is a clinical study titled "Collaboration Oriented Approach to Controlling High Blood Pressure". Hypertension is a significant contributor to poor cardiovascular outcomes. Self-management support tools can increase patient behaviors to improve blood pressure. The investigators created a clinical decision support app, called COACH, to integrate home blood pressure data and goals into EHR reporti...

What is the current status of trial NCT06124716?

This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2024-01-12. Estimated completion is 2026-06-30.

What conditions does trial NCT06124716 study?

This clinical trial studies the following conditions: Hypertension, Multiple Chronic Conditions.

What interventions are being tested in trial NCT06124716?

The interventions under investigation include: Enhanced COACH CDS Tool (OTHER), Usual Care COACH CDS Tool (OTHER).

Who is sponsoring clinical trial NCT06124716?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06124716 being conducted?

This trial has 3 study locations across Missouri, Oregon, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06124716's enrollment target sits among peer trials

550 106th of 470 higher than 364 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

  • NCT02995252 · 550 participants

    The HOPE Study: Characterizing Patients With Hepatitis B and C

  • NCT03474913 · 550 participants

    Upright MRI for Prostate Cancer Screening

  • NCT04761120 · 550 participants

    Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06124716, the US trial registry maintained by the National Library of Medicine. NCT06124716 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.